Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Mechanistic Validation of a Tumor-Derived Extracellular Vesicle-Associated miRNA Signature Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer

NCT07500129 is registered in ClinicalTrials.gov with Atlas University as lead sponsor.

NCT NCT07500129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Mechanistic Validation of a Tumor-Derived Extracellular Vesicle-Associated miRNA Signature Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer
Lead sponsor
Atlas University
Phase
Observational
Overall status
Not yet recruiting
Start date
April 12, 2026
Completion date
April 22, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, exosomal microrna, invasive breast carcinoma, neoadjuvant chemotherapy response, pathological complete response